ZoetisZTS

NYSE · USA · Segment 2 of 8 in the Medicine, pharma & life science value chain: Big pharma

The world’s largest animal health company — medicines and vaccines for pets and livestock, spun off from Pfizer in 2013.

Big pharma: Large, diversified pharmaceutical groups with broad portfolios across therapeutic areas.

Key metrics

Market cap

$32.7B

Price

$76.35

Today

+1.7%

Return YTD

−40.3%

Return 1Y

−52.6%

P/E

12.4

P/S

3.4

P/B

10.1

Data as of 2026-07-10 · updates daily after U.S. close

Theme exposure

Animal healthPetsDefensive growthPet medicineLivestock & foodDiagnostics

In the value chain

Products & services

Simparica (parasiticide)
Librela / Solensia (pain)
Vaccines

Competitors

Merck Animal Health
Elanco
Boehringer Ingelheim

Risks

Pet spending is cyclical
Generic competition

Same segment: Big pharma

Johnson & JohnsonJNJ AbbVieABBV Merck & Co.MRK PfizerPFE Bristol Myers SquibbBMY

See where Zoetis sits in the full Medicine, pharma & life science map — every segment from upstream suppliers to end markets, with daily metrics.Open the Life science value chain →